Luci
Large specimen imaging
Key Facts
About Instapath
Instapath is pioneering a rapid, non-destructive digital pathology platform designed to provide immediate tissue analysis at the point of procedure. Its core technology, the Neo system, is a Class I medical device that uses patented fluorescence microscopy to image fresh tissue without traditional histology processing, saving hours or days in the diagnostic timeline. The company complements its hardware with the Luci imaging system for larger specimens and a remote scanning service (LuciNow), targeting a significant market opportunity in surgical margin assessment and intraoperative diagnostics. As a private, likely pre-revenue company, its success hinges on clinical adoption, regulatory pathways for expanded claims, and competition against established and emerging digital pathology solutions.
View full company profile